ATALAY, R. 2017. Cancer Drug Discovery: Targeting PI3K/AKT/mTOR Cell Survival Pathway. European Bioinformatics Institute (EMBL-EBI) - Shared Facilities , (Cambridge, Canada).

ATALAY, R., (2017). Cancer Drug Discovery: Targeting PI3K/AKT/mTOR Cell Survival Pathway . European Bioinformatics Institute (EMBL-EBI) - Shared Facilities, Cambridge, Canada

ATALAY, RENGÜL. "Cancer Drug Discovery: Targeting PI3K/AKT/mTOR Cell Survival Pathway," European Bioinformatics Institute (EMBL-EBI) - Shared Facilities, Cambridge, Canada, 2017

ATALAY, RENGÜL. "Cancer Drug Discovery: Targeting PI3K/AKT/mTOR Cell Survival Pathway." European Bioinformatics Institute (EMBL-EBI) - Shared Facilities , Cambridge, Canada, 2017

ATALAY, R. (2017) . "Cancer Drug Discovery: Targeting PI3K/AKT/mTOR Cell Survival Pathway." European Bioinformatics Institute (EMBL-EBI) - Shared Facilities , Cambridge, Canada.

@conferencepaper{conferencepaper, author={RENGÜL ATALAY}, title={Cancer Drug Discovery: Targeting PI3K/AKT/mTOR Cell Survival Pathway}, congress name={European Bioinformatics Institute (EMBL-EBI) - Shared Facilities}, city={Cambridge}, country={Canada}, year={2017}}